45 results

Healthy returns: European life sciences M&A heats up as sector faces demographic reckoning
M&A Explorer | Dealmaking in Europe's life sciences sector has been relatively muted in recent years, but the first half of 2025 has shown signs of strength as companies respond to the stark realities of an aging population

Minority report: Minority stakes spike in US and Europe for sponsors and strategics alike
M&A Explorer | In an M&A market characterized by buyer caution and narrowing liquidity pathways for sellers, flexible minority stakes transactions are proving a valuable option for dealmakers in the US and Europe

Global merger control: Navigating stormy seas
There have been a number of developments in merger control in 2020 and Q1 2021. Some are related to the repercussions of the COVID-19 pandemic, while others are borne out of the ambitions and changes sought by individual competition authorities or unexpected jurisprudence